Investing Ideas
/
New Zealand Pharmaceuticals & Biotech High Insider Buying

New Zealand Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Pacific Edge

Market Cap: NZ$316.7m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.25

-3.8%

88.0%